Etravirine Concentrations in the Cervicovaginal Compartment in HIV-1-Infected Women Receiving Etravirine-Containing Antiretroviral Therapy: DIVA 02 Study

We studied the penetration of etravirine and HIV shedding in the genital tract among 12 HIV-1-infected women receiving an etravirine-containing regimen who had <40 copies/ml blood plasma (BP) HIV RNA. None of the cervicovaginal fluid (CVF) samples showed detectable HIV RNA. Median etravirine conc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Clavel, C., Peytavin, G., Tubiana, R., Soulié, C., Courbon, E., Crenn-Hebert, C., Ichou, H., Blanc, C., Schneider, L., Katlama, C., Marcelin, A.-G., Mandelbrot, L.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2012
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3393414/
https://ncbi.nlm.nih.gov/pubmed/22526321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.06474-11
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados